Rank
447
Quintiles IMS Holdings
Courtesy of Quintiles Transnational Holdings
- Revenues ($M)5738
- Revenue Percent Change5.1
- Profits ($M)387
- Profits Percent Change8.6
- Assets ($M)3926
- Employees36100
- Market Value — as of March 31, 2016 ($M)7780
- Previous Rank476
- Morning Consult Brand IndexC+
The global contract-research firm conducts clinical trials and other activities for pharmaceutical companies.
Company Info
| CEO | Ari Bousbib |
| Sector | Health Care |
| Industry | Health Care: Pharmacy and Other Services |
| HQ Location | Durham, NC |
| Website | www.quintilesims.com |
| Years on Fortune 500 List | 3 |
| Employees | 36,100 |
Key Financials (last fiscal year)
| Revenues ($M) | $5,738 |
| Profits ($M) | $387 |
| Assets ($M) | $3,926 |
| Total Stockholder Equity ($M) | $-564 |
| Market Value — as of March 31, 2016 ($M) | $7,780 |
Profit Ratios
| Profit as % of Revenues | 6.7% |
| Profits as % of Assets | 9.9% |
| Profits as % of Stockholder Equity | - |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 308 |
| EPS % Change (from 2014) | 13.2% |
| EPS % Change (5 year annual rate) | - |
| EPS % Change (10 year annual rate) | - |
Total Return
| Total Return to Investors (2015) | 16.6% |
| Total Return to Investors (5 year, annualized) | - |
| Total Return to Investors (10 year, annualized) | - |